Legacy Specialty Pharmacy Flips to New Owners – BioMatrix

Earlier this week we sent a Report on Walmart opening twenty-five specialty pharmacies. That was about organic growth. Today we are reporting on the changing hands of a long-established specialty pharmacy, BioMatrix Specialty Infusion Pharmacy…. which is likely to also be a story about growth.

Headquartered in Plantation, Florida, BioMatrix was formed in 2015 through the merger of Matrix Health Group and BiologicTx, two specialty pharmacy companies.  With a network of seven pharmacies, the Company became a leading provider for patients with blood disorders, organ transplants and other chronic and acute diseases and conditions.  

In 2016, BioMatrix was acquired by Acon Investments leading to carving out low-margin oral therapies in favor of pursuing higher-margin infused therapies in opportune growth categories. Unlike more recent transactions, Acon sold its investment position in BioMatrix to another investment firm, Frazier Healthcare Partners. It will be interesting to see what the next iteration of BioMatrix will look like in the next years.

——————————————————————————————–

ACON COMPLETES SALE OF BIOMATRIX SPECIALTY INFUSION PHARMACY

CLICK HERE to read the full press release

Share:

Read More

Limited Distribution Updates

Announcements for newly approved specialty drugs often state that the product will be available through specialty pharmacy in limited distribution. However, the early press releases

FDA Approves Oral Tx for Breast Cancer – Itovebi

…………………………catching up on FDA approvals The FDA recently approved an ORAL therapy, Itovebi (inavolisib) from Genentech, Inc. Itovebi is indicated in combination with palbociclib and fulvestrant for

Send Us A Message

This website uses cookies to ensure you get the best experience on our website.